188 related articles for article (PubMed ID: 26308071)
1. AMF/PGI-mediated tumorigenesis through MAPK-ERK signaling in endometrial carcinoma.
Li Y; Jia Y; Che Q; Zhou Q; Wang K; Wan XP
Oncotarget; 2015 Sep; 6(28):26373-87. PubMed ID: 26308071
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of phosphoglucose isomerase/autocrine motility factor enhances gensenoside Rh2 pharmacological action on leukemia KG1α cells.
You ZM; Zhao L; Xia J; Wei Q; Liu YM; Liu XY; Chen DL; Li J
Asian Pac J Cancer Prev; 2014; 15(3):1099-104. PubMed ID: 24606425
[TBL] [Abstract][Full Text] [Related]
3. Suppression of AMF/PGI-mediated tumorigenic activities by ursolic acid in cultured hepatoma cells and in a mouse model.
Shih WL; Yu FL; Chang CD; Liao MH; Wu HY; Lin PY
Mol Carcinog; 2013 Oct; 52(10):800-12. PubMed ID: 22549898
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells.
Funasaka T; Hu H; Yanagawa T; Hogan V; Raz A
Cancer Res; 2007 May; 67(9):4236-43. PubMed ID: 17483335
[TBL] [Abstract][Full Text] [Related]
5. Silencing of phosphoglucose isomerase/autocrine motility factor decreases U87 human glioblastoma cell migration.
Li Y; Wei Z; Dong B; Lian Z; Xu Y
Int J Mol Med; 2016 Apr; 37(4):998-1004. PubMed ID: 26936801
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of the autocrine motility factor/phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblasts.
Tsutsumi S; Hogan V; Nabi IR; Raz A
Cancer Res; 2003 Jan; 63(1):242-9. PubMed ID: 12517804
[TBL] [Abstract][Full Text] [Related]
7. Raft-dependent endocytosis of autocrine motility factor/phosphoglucose isomerase: a potential drug delivery route for tumor cells.
Kojic LD; Wiseman SM; Ghaidi F; Joshi B; Nedev H; Saragovi HU; Nabi IR
PLoS One; 2008; 3(10):e3597. PubMed ID: 18974847
[TBL] [Abstract][Full Text] [Related]
8. Silencing of autocrine motility factor induces mesenchymal-to-epithelial transition and suppression of osteosarcoma pulmonary metastasis.
Niinaka Y; Harada K; Fujimuro M; Oda M; Haga A; Hosoki M; Uzawa N; Arai N; Yamaguchi S; Yamashiro M; Raz A
Cancer Res; 2010 Nov; 70(22):9483-93. PubMed ID: 20978190
[TBL] [Abstract][Full Text] [Related]
9. Autocrine motility factor promotes endometrial cancer progression by targeting GPER-1.
Li Y; Jia Y; Bian Y; Tong H; Qu J; Wang K; Wan XP
Cell Commun Signal; 2019 Mar; 17(1):22. PubMed ID: 30836961
[TBL] [Abstract][Full Text] [Related]
10. Regulation of phosphoglucose isomerase/autocrine motility factor expression by hypoxia.
Funasaka T; Yanagawa T; Hogan V; Raz A
FASEB J; 2005 Sep; 19(11):1422-30. PubMed ID: 16126909
[TBL] [Abstract][Full Text] [Related]
11. The secreted glycolytic enzyme GPI/AMF stimulates glioblastoma cell migration and invasion in an autocrine fashion but can have anti-proliferative effects.
Kathagen-Buhmann A; Maire CL; Weller J; Schulte A; Matschke J; Holz M; Ligon KL; Glatzel M; Westphal M; Lamszus K
Neuro Oncol; 2018 Nov; 20(12):1594-1605. PubMed ID: 30053149
[TBL] [Abstract][Full Text] [Related]
12. Phosphoglucose isomerase/autocrine motility factor promotes melanoma cell migration through ERK activation dependent on autocrine production of interleukin-8.
Araki K; Shimura T; Yajima T; Tsutsumi S; Suzuki H; Okada K; Kobayashi T; Raz A; Kuwano H
J Biol Chem; 2009 Nov; 284(47):32305-11. PubMed ID: 19801670
[TBL] [Abstract][Full Text] [Related]
13. Autocrine motility factor signaling enhances pancreatic cancer metastasis.
Tsutsumi S; Yanagawa T; Shimura T; Kuwano H; Raz A
Clin Cancer Res; 2004 Nov; 10(22):7775-84. PubMed ID: 15570012
[TBL] [Abstract][Full Text] [Related]
14. Regulation of phosphoglucose isomerase/autocrine motility factor activities by the poly(ADP-ribose) polymerase family-14.
Yanagawa T; Funasaka T; Tsutsumi S; Hu H; Watanabe H; Raz A
Cancer Res; 2007 Sep; 67(18):8682-9. PubMed ID: 17875708
[TBL] [Abstract][Full Text] [Related]
15. Regulation of cell proliferation by autocrine motility factor/phosphoglucose isomerase signaling.
Tsutsumi S; Yanagawa T; Shimura T; Fukumori T; Hogan V; Kuwano H; Raz A
J Biol Chem; 2003 Aug; 278(34):32165-72. PubMed ID: 12783864
[TBL] [Abstract][Full Text] [Related]
16. Autocrine motility factor modulates EGF-mediated invasion signaling.
Kho DH; Zhang T; Balan V; Wang Y; Ha SW; Xie Y; Raz A
Cancer Res; 2014 Apr; 74(8):2229-37. PubMed ID: 24576828
[TBL] [Abstract][Full Text] [Related]
17. Autocrine motility factor promotes epithelial-mesenchymal transition in endometrial cancer via MAPK signaling pathway.
Li Y; Che Q; Bian Y; Zhou Q; Jiang F; Tong H; Ke J; Wang K; Wan XP
Int J Oncol; 2015 Sep; 47(3):1017-24. PubMed ID: 26201353
[TBL] [Abstract][Full Text] [Related]
18. DPPIV promotes endometrial carcinoma cell proliferation, invasion and tumorigenesis.
Yang X; Zhang X; Wu R; Huang Q; Jiang Y; Qin J; Yao F; Jin G; Zhang Y
Oncotarget; 2017 Jan; 8(5):8679-8692. PubMed ID: 28060721
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of phosphoglucose isomerase/autocrine motility factor activities by protein kinase CK2 phosphorylation.
Yanagawa T; Funasaka T; Tsutsumi S; Raz T; Tanaka N; Raz A
J Biol Chem; 2005 Mar; 280(11):10419-26. PubMed ID: 15637053
[TBL] [Abstract][Full Text] [Related]
20. Induction of hepatoma cells migration by phosphoglucose isomerase/autocrine motility factor through the upregulation of matrix metalloproteinase-3.
Yu FL; Liao MH; Lee JW; Shih WL
Biochem Biophys Res Commun; 2004 Jan; 314(1):76-82. PubMed ID: 14715248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]